AI: DeepSeek (deepseek-chat)

Q: {
  "guidelineId": "sp22007-im-methotrexate-sop-and-competency-document-pdf",
  "fieldsProcessed": [
    "humanFriendlyName",
    "organisation",
    "yearProduced",
    "summary"
  ],
  "enhancedFields": 4,
  "contentLength": 5156
}

A: {
  "success": true,
  "enhancedFields": [
    {
      "field": "humanFriendlyName",
      "oldValue": null,
      "newValue": "Guidelines for Intramuscular Methotrexate in Ectopic Pregnancy and Trophoblastic Disease",
      "action": "added"
    },
    {
      "field": "organisation",
      "oldValue": null,
      "newValue": "RCOG",
      "action": "added"
    },
    {
      "field": "yearProduced",
      "oldValue": null,
      "newValue": "The provided text does not contain a publication year. If you have another document or can provide the year, I'd be happy to extract it for you",
      "action": "added"
    },
    {
      "field": "summary",
      "oldValue": null,
      "newValue": "**Summary of Intramuscular Methotrexate Clinical SOP for Ectopic Pregnancy/Persistent Trophoblastic Disease** **Purpose**: Ensure safe administration of IM Methotrexate for ectopic pregnancy or persistent gestational trophoblastic disease (PGTD). **Key Recommendations**: - **Ectopic Pregnancy**: Dose calculated as 50 mg/mÂ² (BSA-based), with strict patient selection criteria. - **PGTD**: Chemotherapy may be required for molar pregnancies, with ongoing monitoring. - **Contraindications**: Allergy to Methotrexate, significant ectopic pain/bleeding, or abnormal renal/liver function. - **Informed Consent**: Mandatory before administration. - **Precautions**: Administering staff must not be pregnant; follow cytotoxic handling/disposal protocols. - **Side Effects**: Include injection site reactions, ulceration, bleeding, and photosensitivity. - **Administration**: Use Z-track technique in gluteus maximus; aspirate before injecting. - **Monitoring**: Track incidents and staff competency. **Procedure Steps**: 1. Verify prescription, patient details, and consent. 2. Administer via IM route using aseptic technique. 3. Dispose of waste in cytotoxic bins. 4. Manage spills with cytotoxic spill kit. **Competency**: Staff must complete training and demonstrate understanding of SOP before administering Methotrexate",
      "action": "added"
    }
  ]
}